Barclays raised the firm’s price target on Keurig Dr Pepper to $42 from $40 and keeps an Overweight rating on the shares ahead of the Q1 results. Within the firm’s staples universe, the analyst continues to favor names that have greater visibility to volume growth, either through enhanced category exposure or idiosyncratic factors.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on KDP:
- Keurig Dr Pepper price target lowered to $36 from $38 at Deutsche Bank
- Keurig Dr Pepper 3M share Block Trade priced at $34.60
- Keurig Dr Pepper 3M share Block Trade; price range $34.55-$35.00
- Keurig Dr Pepper price target lowered to $40 from $45 at Barclays
- Keurig Dr Pepper sees FY23 adjusted EPS up 6%-7%, consensus $1.79